Vivo Capital, LLC Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$1.4T
Holdings
48
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (48 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SVASinovac Biotech Ltd. | 5,900,000 | $615.4B | 42.70% | |
| 2 | —Genetron Holdings Ltd | 8,124,174 | $104.6B | 7.26% | |
| 3 | VRNAVerona Pharma PLC | 4,249,918 | $85.3B | 5.92% | |
| 4 | HRMYHarmony Biosciences Holdings Inc | 2,606,247 | $85.1B | 5.90% | |
| 5 | TERNTerns Pharmaceuticals Inc | 6,657,992 | $78.8B | 5.47% | |
| 6 | VRDNViridian Therapeutics Inc | 1,678,207 | $42.7B | 2.96% | |
| 7 | GONGeron Corp | 19,282,834 | $41.8B | 2.90% | |
| 8 | AVDLAvadel Pharmaceuticals PLC | 3,761,438 | $34.5B | 2.39% | |
| 9 | TARSTarsus Pharmaceuticals Inc | 2,262,200 | $28.4B | 1.97% | |
| 10 | CATBUSDAstria Therapeutics Inc | 1,681,199 | $22.4B | 1.55% | |
| 11 | PCVXVaxcyte Inc | 579,508 | $21.7B | 1.51% | |
| 12 | COGTCogent Biosciences Inc | 1,994,941 | $21.5B | 1.49% | |
| 13 | 290AChinook Therapeutics Inc | 872,151 | $20.2B | 1.40% | |
| 14 | VTYXVentyx Biosciences Inc | 602,075 | $20.2B | 1.40% | |
| 15 | —VectivBio Holding AG | 2,333,300 | $19.9B | 1.38% | |
| 16 | ALXOALX Oncology Holdings Inc | 4,220,048 | $19.1B | 1.32% | |
| 17 | ALLKGUSDAllakos Inc | 4,120,134 | $18.3B | 1.27% | |
| 18 | ZLABZai Lab Ltd ADR | 416,640 | $13.9B | 0.96% | |
| 19 | LEGNLegend Biotech Corp Sponsored | 244,375 | $11.8B | 0.82% | |
| 20 | CMPXCompass Therapeutics Inc | 3,556,023 | $11.6B | 0.81% | |
| 21 | AMRSEURAmyris, Inc | 7,750,828 | $10.5B | 0.73% | |
| 22 | ACLXArcellx Inc. | 290,713 | $9.0B | 0.62% | |
| 23 | TILInstil Bio Inc | 12,486,787 | $8.3B | 0.57% | |
| 24 | BLUBellus Health Inc | 1,017,152 | $7.3B | 0.51% | |
| 25 | ACRSAclaris Therapeutics, Inc. | 898,631 | $7.3B | 0.50% | |
| 26 | SERASera Prognostics Inc | 1,856,011 | $7.1B | 0.49% | |
| 27 | KALVKalVista Pharmaceuticals Inc. | 856,008 | $6.7B | 0.47% | |
| 28 | DYNDyne Therapeutics Inc | 577,642 | $6.7B | 0.46% | |
| 29 | MRUSMerus NV | 353,600 | $6.5B | 0.45% | |
| 30 | WHWKAadi Bioscience Inc | 509,572 | $6.5B | 0.45% | |
| 31 | OLMAOlema Pharmaceuticals Inc | 1,689,515 | $5.9B | 0.41% | |
| 32 | IOBTIO Biotech Inc | 3,015,545 | $5.7B | 0.39% | |
| 33 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $5.4B | 0.37% | |
| 34 | —DBV Technologies SA | 2,708,875 | $4.6B | 0.32% | |
| 35 | —Impel NeuroPharma Inc | 2,884,789 | $4.0B | 0.28% | |
| 36 | IOVAIovance Biotherapeutics Inc | 655,057 | $4.0B | 0.28% | |
| 37 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $3.5B | 0.24% | |
| 38 | ALGSAligos Therapeutics Inc | 3,547,030 | $3.1B | 0.22% | |
| 39 | GRCLGracell Biotechnologies Inc | 1,463,983 | $2.7B | 0.19% | |
| 40 | BCABBioAtla Inc | 637,181 | $1.7B | 0.12% | |
| 41 | —Aslan Pharmaceuticals Ltd | 2,840,909 | $1.6B | 0.11% | |
| 42 | CDXSCodexis, Inc | 388,144 | $1.6B | 0.11% | |
| 43 | FULCFulcrum Therapeutics Inc | 550,000 | $1.6B | 0.11% | |
| 44 | IMUXImmunic Inc | 632,184 | $942.0M | 0.07% | |
| 45 | RZLTRezolute Inc | 489,473 | $939.8M | 0.07% | |
| 46 | —Minerva Surgical Inc | 2,215,667 | $486.3M | 0.03% | |
| 47 | FIXXEURHomology Medicines, Inc. | 370,068 | $381.2M | 0.03% | |
| 48 | DTILPrecision Biosciences Inc | 140,255 | $105.7M | 0.01% |